ID   3BHS5_RAT               Reviewed;         373 AA.
AC   P27364; Q569C6;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 162.
DE   RecName: Full=NADPH-dependent 3-keto-steroid reductase Hsd3b5 {ECO:0000305|PubMed:1537836};
DE   AltName: Full=3 beta-hydroxysteroid dehydrogenase type 3;
DE   AltName: Full=3 beta-hydroxysteroid dehydrogenase type III {ECO:0000305|PubMed:1537836};
DE            Short=3 beta-HSD III;
DE            EC=1.1.1.270 {ECO:0000269|PubMed:1537836};
DE   AltName: Full=Dihydrotestosterone 3-ketoreductase {ECO:0000305|PubMed:1537836};
DE            EC=1.1.1.210 {ECO:0000269|PubMed:1537836};
GN   Name=Hsd3b5 {ECO:0000312|RGD:2838}; Synonyms=Hsd3b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=2249649; DOI=10.1210/endo-127-6-3237;
RA   Zhao H.-F., Rheaume E., Trudel C., Couet J., Labrie F., Simard J.;
RT   "Structure and sexual dimorphic expression of a liver-specific rat 3 beta-
RT   hydroxysteroid dehydrogenase/isomerase.";
RL   Endocrinology 127:3237-3239(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE
RP   SPECIFICITY, AND PATHWAY.
RX   PubMed=1537836; DOI=10.1016/s0021-9258(18)42863-3;
RA   de Launoit Y., Zhao H.F., Belanger A., Labrie F., Simard J.;
RT   "Expression of liver-specific member of the 3 beta-hydroxysteroid
RT   dehydrogenase family, an isoform possessing an almost exclusive 3-
RT   ketosteroid reductase activity.";
RL   J. Biol. Chem. 267:4513-4517(1992).
CC   -!- FUNCTION: Responsible for the reduction of the oxo group on the C-3 of
CC       5alpha-androstane steroids. Catalyzes the conversion of
CC       dihydrotestosterone to its inactive form 5alpha-androstanediol, that
CC       does not bind androgen receptor/AR. Also converts androstanedione, a
CC       precursor of testosterone and estrone, to epiandrosterone. Does not
CC       function as an isomerase. {ECO:0000269|PubMed:1537836}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 3beta-hydroxysteroid + NADP(+) = a 3-oxosteroid + H(+) +
CC         NADPH; Xref=Rhea:RHEA:34787, ChEBI:CHEBI:15378, ChEBI:CHEBI:36836,
CC         ChEBI:CHEBI:47788, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.270; Evidence={ECO:0000269|PubMed:1537836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5alpha-androstane-3beta,17beta-diol + NADP(+) = 17beta-
CC         hydroxy-5alpha-androstan-3-one + H(+) + NADPH; Xref=Rhea:RHEA:16297,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16330, ChEBI:CHEBI:18329,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.210;
CC         Evidence={ECO:0000269|PubMed:1537836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3beta-hydroxy-5alpha-androstan-17-one + NADP(+) = 5alpha-
CC         androstan-3,17-dione + H(+) + NADPH; Xref=Rhea:RHEA:56916,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15994, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:541975;
CC         Evidence={ECO:0000269|PubMed:1537836};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.12 uM for dihydrotestosterone (in the presence of NADPH)
CC         {ECO:0000269|PubMed:1537836};
CC         KM=6.16 uM for dihydrotestosterone (in the presence of NADH)
CC         {ECO:0000269|PubMed:1537836};
CC         Note=Catalytic efficiency for dihydrotestosterone reduction is 20-
CC         fold better in the presence of NADPH than in the presence of NADH.
CC         {ECO:0000269|PubMed:1537836};
CC   -!- PATHWAY: Steroid metabolism. {ECO:0000269|PubMed:1537836}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein. Mitochondrion membrane; Single-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in male liver.
CC       {ECO:0000269|PubMed:2249649}.
CC   -!- SIMILARITY: Belongs to the 3-beta-HSD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M67465; AAA41352.1; -; mRNA.
DR   EMBL; BC092571; AAH92571.1; -; mRNA.
DR   PIR; A37404; A37404.
DR   RefSeq; NP_036716.1; NM_012584.1.
DR   AlphaFoldDB; P27364; -.
DR   STRING; 10116.ENSRNOP00000072555; -.
DR   CarbonylDB; P27364; -.
DR   iPTMnet; P27364; -.
DR   PhosphoSitePlus; P27364; -.
DR   PaxDb; 10116-ENSRNOP00000026290; -.
DR   Ensembl; ENSRNOT00055056713; ENSRNOP00055046819; ENSRNOG00055032797.
DR   Ensembl; ENSRNOT00060023537; ENSRNOP00060018693; ENSRNOG00060013782.
DR   Ensembl; ENSRNOT00065053181; ENSRNOP00065043678; ENSRNOG00065030863.
DR   GeneID; 24470; -.
DR   KEGG; rno:24470; -.
DR   UCSC; RGD:2838; rat.
DR   AGR; RGD:2838; -.
DR   CTD; 15496; -.
DR   RGD; 2838; Hsd3b5.
DR   eggNOG; KOG1430; Eukaryota.
DR   InParanoid; P27364; -.
DR   OrthoDB; 3675908at2759; -.
DR   PhylomeDB; P27364; -.
DR   TreeFam; TF343138; -.
DR   Reactome; R-RNO-193048; Androgen biosynthesis.
DR   Reactome; R-RNO-193993; Mineralocorticoid biosynthesis.
DR   Reactome; R-RNO-194002; Glucocorticoid biosynthesis.
DR   PRO; PR:P27364; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity; IDA:RGD.
DR   GO; GO:0000253; F:3-keto sterol reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047024; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IBA:GO_Central.
DR   GO; GO:0005496; F:steroid binding; IDA:RGD.
DR   GO; GO:0016229; F:steroid dehydrogenase activity; TAS:RGD.
DR   GO; GO:0008207; P:C21-steroid hormone metabolic process; IBA:GO_Central.
DR   GO; GO:0021766; P:hippocampus development; IBA:GO_Central.
DR   GO; GO:0042448; P:progesterone metabolic process; IDA:RGD.
DR   GO; GO:0050810; P:regulation of steroid biosynthetic process; IDA:RGD.
DR   GO; GO:0051412; P:response to corticosterone; IBA:GO_Central.
DR   GO; GO:0006694; P:steroid biosynthetic process; IDA:RGD.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR002225; 3Beta_OHSteriod_DH/Estase.
DR   InterPro; IPR050177; Lipid_A_modif_metabolic_enz.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   PANTHER; PTHR43245; BIFUNCTIONAL POLYMYXIN RESISTANCE PROTEIN ARNA; 1.
DR   PANTHER; PTHR43245:SF51; SHORT CHAIN DEHYDROGENASE_REDUCTASE FAMILY 42E, MEMBER 2; 1.
DR   Pfam; PF01073; 3Beta_HSD; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Endoplasmic reticulum; Lipid metabolism; Membrane;
KW   Mitochondrion; NADP; Oxidoreductase; Reference proteome;
KW   Steroid metabolism; Transmembrane; Transmembrane helix.
FT   CHAIN           1..373
FT                   /note="NADPH-dependent 3-keto-steroid reductase Hsd3b5"
FT                   /id="PRO_0000087789"
FT   TRANSMEM        288..308
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        159
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:Q12068"
FT   BINDING         10..15
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q12068"
FT   BINDING         155
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q12068"
FT   BINDING         159
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q12068"
FT   MOD_RES         350
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61694"
FT   CONFLICT        180
FT                   /note="F -> L (in Ref. 2; AAH92571)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="R -> T (in Ref. 2; AAH92571)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   373 AA;  42206 MW;  B96538F2EF056935 CRC64;
     MPGWSCLVTG AGGFLGQRIV QMLVQEKELQ EVRVLYRTFS PKHKEELSKL QTKAKVTVLR
     GDIVDAQFLR RACQGMSVII HTAAALDIAG FLPRQTILDV NVKGTQLLLD ACVEASVPAF
     IYSSSTGVAG PNSYKETILN DREEEHREST WSNPYPYSKR MAEKAVLAAN GSILKNGGTF
     HTCALRLPFI YGEESQIIST MVNRALKNNS IIKRHATFSI ANPVYVGNAA WAHILAARGL
     RDPEKSQSIQ GQFYYISDDT PHQSYDDLNY TLSKEWGFCL DSSWSLPLPL LYWLAFLLET
     VSFLLRPFYN YRPPFNRFMV TILNSVFTIS YKKAQRDLGY EPLVSWEEAK QKTSEWIGTL
     VEQHRETLDT KSQ
//
